Frascati-mediated Mitochondrial Metabolism
Frascati-mediated Mitochondrial Metabolism
批准号:
8693645
负责人:
BARRY H PAW
金额:
$32.41万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
AnabolismAnemiaBioinformaticsCandidate Disease GeneCell LineCell physiologyCellsDefectDevelopmental BiologyEmbryoEndosomesEpitopesErythrocytesErythroidErythroid CellsErythropoiesisFetal LiverFollow-Up StudiesGene ExpressionGenerationsGenesGeneticGoalsHemeHeme IronHemoglobinHepatocyteHumanInstructionIronIron Metabolism DisordersKnock-outLiverMammalian CellMammalsMass Spectrum AnalysisMediatingMessenger RNAMetabolismMitochondriaMitochondrial Membrane ProteinMitochondrial ProteinsMusOrganOrthologous GenePhenotypePopulationPrimary Cell CulturesProsthesisProteinsProteomeRoleStructural GenesStructural ProteinStructureValidationZebrafishferrochelataseheme biosynthesisinsightinterestloss of functionnovelprotein complextooltrafficking
中文摘要
这项提案的目标是识别和表征与线粒体有关的新蛋白质。
用mRNA测序(RNAseq)鉴定区分胎肝群体的铁/血红素代谢
和生物信息学方法。血红素是血液蛋白中的一个修饰性基团,具有广泛的
在这些关键的细胞过程中,红细胞中的血红蛋白合成是最广为人知的。尽管
细胞质铁转运和原卟啉生物合成的研究进展
保留,尤其是涉及铁从内体向外排出的成分
线粒体,铁/血红素在线粒体内的运输,以及最终从线粒体输出的血红素
线粒体为其与血红蛋白的结合。近年来,我们已经确定了
L Litoferrin1(L,SLC25a37)铁导入蛋白及其与其他线粒体蛋白的相互作用
铁络合酶,在线粒体铁的获取及其在血红素合成中的应用。为了试图
鉴定对血红素合成重要的其他未知成分,我们筛选了数千种
与已知的血红素紧密共表达和共同调控的基因微阵列
生物合成基因以确定潜在的有趣的、新的候选基因。对这些问题的后续研究
斑马鱼中的候选基因表明,使用反义吗啉,
在所有病例中都导致严重贫血。在一种补充方法中,我们最近分析了
具有预测跨膜基序、转运蛋白功能或定位的结构蛋白表达
经RNAseq分析鉴定为分化胎肝细胞的线粒体。我们
鉴定了另外9个强诱导基因,它们在红系铁/血红素代谢中的功能尚未见报道
已经被研究过了。我们建议研究这9个基因的表达和功能丧失表型。
结构基因(c20orf108、Snx3、Slc43a1、Slc43a3、Slc7a5、Ehbplll、Tmcc2、Slc38a5、Tem14c)
斑马鱼和哺乳动物细胞。特别是,我们计划将重点放在这些新发现的来自
这两个生物信息学筛选,Tem14c,一个功能未知的小线粒体膜蛋白。
相关性(请参阅说明):
为了阐明这8种结构蛋白的功能,Tem14c及其相互作用的蛋白质伙伴可能会给出
深入了解线粒体血红素代谢的未知步骤,为探索提供新的遗传工具
人类铁/血红素代谢紊乱与红细胞生成。
英文摘要
The objectives of this proposal are to identify and characterize novel proteins involved in mitochondrial
iron/heme metabolism identified from differentiating fetal liver population by mRNA sequencing (RNAseq)
and bioinformatics approaches. Heme serves as a prosthetic group in hemo-proteins for a wide array of
crucial cellular processes, and of these, hemoglobin synthesis in red cells is the most well known. Despite
advances in our understanding of cytosolic iron trafficking and proto-prophyrin biosynthesis, significant gaps
remain, especially, with respect to components involving the egress of iron from the endosomes to the
mitochondria, the trafficking of iron/heme within the mitochondria, and the eventual export of heme from the
mitochondria for its incorporation in hemoglobin. In recent years, we have characterized the role ofthe
l\/litoferrin1 (l\/lfrn1, Slc25a37) iron importer and its interaction with other mitochondrial proteins, AbcblO and
ferrochelatase, in the acquisition of mitochondrial iron and its utilization in heme synthesis. In an attempt to
dentify additional, unknown components important for heme synthesis, we screened thousands of
microarrays for genes that were tightly co-expressed and co-regulated with previously known heme
biosynthesis genes to identify potentially interesting, novel candidate genes. Follow up studies of these
candidate genes in the zebrafish showed that gene-specific knockdown, using anti-sense morpholinos,
resulted in profound anemia in all cases. In a complementary approach, we recently analyzed the
expression of structural proteins with predicted transmembrane motifs, transporter function, or localization to
the mitochondria, which were identified by RNAseq analysis from differentiating fetal liver cells. We
identified 9 additional strongly induced genes, whose function in erythroid iron/heme metabolism has not
been previously studied. We propose to study the expression and loss-of-function phenotype of these 9
structural genes (c20orf108, Snx3, Slc43a1, Slc43a3, Slc7a5, Ehbplll, Tmcc2, Slc38a5, Tmem14c) in the
zebrafish and mammalian cells. In particular, we plan to focus on one of these newly identified genes from
the two bioinformatics screens, Tmem14c, a small mitochondrial membrane protein of unknown function.
RELEVANCE (See instructions):
Elucidating the function of these 8 structural proteins, Tmem14c and its interacting protein partners may give
insight into unknown steps in mitochondrial heme metabolism and provide new genetic tools for exploring
human disorders of iron/heme metabolism and erythropoiesis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Frascati-mediated Mitochondrial Metabolism
-
批准号:8205189
-
项目类别:
-
资助金额:$35.68万
-
财政年份:2011
-
负责人:BARRY H PAW
-
依托单位:
Frascati: mitochondrial transporter and erythropoiesis
-
批准号:7566038
-
项目类别:
-
资助金额:$35.16万
-
财政年份:2007
-
负责人:BARRY H PAW
-
依托单位:
Frascati: mitochondrial transporter and erythropoiesis
-
批准号:7350215
-
项目类别:
-
资助金额:$35.16万
-
财政年份:2007
-
负责人:BARRY H PAW
-
依托单位:
Frascati-mediated Iron Metabolism in Erythroblasts
-
批准号:7458644
-
项目类别:
-
资助金额:$27.89万
-
财政年份:2007
-
负责人:BARRY H PAW
-
依托单位:
Frascati: mitochondrial transporter and erythropoiesis
-
批准号:7211687
-
项目类别:
-
资助金额:$35.88万
-
财政年份:2007
-
负责人:BARRY H PAW
-
依托单位:
Frascati: mitochondrial transporter and erythropoiesis
-
批准号:8052887
-
项目类别:
-
资助金额:$34.46万
-
财政年份:2007
-
负责人:BARRY H PAW
-
依托单位:
Frascati-mediated Iron Metabolism in Erythroblasts
-
批准号:7217636
-
项目类别:
-
资助金额:$25.88万
-
财政年份:2006
-
负责人:BARRY H PAW
-
依托单位:
GENETIC ANALYSIS--DYSERYTHROPOIETIC ANEMIA IN ZEBRAFISH
-
批准号:2679126
-
项目类别:
-
资助金额:$10.79万
-
财政年份:1998
-
负责人:BARRY H PAW
-
依托单位:
GENETIC ANALYSIS--DYSERYTHROPOIETIC ANEMIA IN ZEBRAFISH
-
批准号:2905017
-
项目类别:
-
资助金额:$12.04万
-
财政年份:1998
-
负责人:BARRY H PAW
-
依托单位:
GENETIC ANALYSIS--DYSERYTHROPOIETIC ANEMIA IN ZEBRAFISH
-
批准号:6176952
-
项目类别:
-
资助金额:$12.04万
-
财政年份:1998
-
负责人:BARRY H PAW
-
依托单位:
Frascati-mediated Iron Metabolism in Erythroblasts
-
批准号:8102790
-
项目类别:
-
资助金额:$38.18万
-
财政年份:--
-
负责人:BARRY H PAW
-
依托单位:
Frascati-mediated Mitochondrial Metabolism
-
批准号:8515498
-
项目类别:
-
资助金额:$31.73万
-
财政年份:--
-
负责人:BARRY H PAW
-
依托单位:
Project 5 Frascati-mediated Mitochondrial Metabolism, Barry Paw
-
批准号:9276321
-
项目类别:
-
资助金额:$33.62万
-
财政年份:--
-
负责人:BARRY H PAW
-
依托单位:
Frascati-mediated Mitochondrial Metabolism
-
批准号:8379736
-
项目类别:
-
资助金额:$33.58万
-
财政年份:--
-
负责人:BARRY H PAW
-
依托单位:
Frascati-mediated Iron Metabolism in Erythroblasts
-
批准号:7885343
-
项目类别:
-
资助金额:$37.05万
-
财政年份:--
-
负责人:BARRY H PAW
-
依托单位:
Frascati-mediated Iron Metabolism in Erythroblasts
-
批准号:7652275
-
项目类别:
-
资助金额:$35.24万
-
财政年份:--
-
负责人:BARRY H PAW
-
依托单位:
Frascati-mediated Mitochondrial Metabolism
-
批准号:8889294
-
项目类别:
-
资助金额:$36.23万
-
财政年份:--
-
负责人:BARRY H PAW
-
依托单位:
国内基金
海外基金
基于构建骨骼类器官模型探究Fanconi anemia信号通路调控电刺激诱导神经化成骨过程的机制研究
-
批准号:82302715
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:熊泽康
-
依托单位:
FANCM蛋白在传统Fanconi anemia通路以外对保护基因组稳定性的功能
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2021
-
负责人:陈英伟
-
依托单位:
范可尼贫血(Fanconi Anemia)基因FANCM在复制后修复中的作用及FA癌症抑制通路的机制研究
-
批准号:31200592
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2012
-
负责人:孙伟力
-
依托单位: